Hui Yin Yow - Search Results

Year	Number of Results
2013	1
2021	2
2022	3
2023	3
2024	4

1

Novel drug candidates against antibiotic-resistant microorganisms: A review.

Lim JS, Chai YY, Ser WX, Haeren AV, Lim YH, Raja T, Foo JB, Hamzah S, Sellappans R, Yow HY. Lim JS, et al. Among authors: yow hy. Iran J Basic Med Sci. 2024;27(2):134-150. doi: 10.22038/IJBMS.2023.71672.15593. Iran J Basic Med Sci. 2024. PMID: 38234674 Free PMC article. Review.

2

Mechanisms of natural products as potential antiepileptic drugs.

Ahmad N, Hui-Yin Y, Makmor-Bakry M. Ahmad N, et al. Among authors: hui yin y. Pak J Pharm Sci. 2022 Jul;35(4):1043-1053. Pak J Pharm Sci. 2022. PMID: 36008901 Review.

3

Pathogenesis of epilepsy: challenges in animal models.

Hui Yin Y, Ahmad N, Makmor-Bakry M. Hui Yin Y, et al. Iran J Basic Med Sci. 2013 Nov;16(11):1119-32. Iran J Basic Med Sci. 2013. PMID: 24494063 Free PMC article. Review.

4

Pharmacogenomics of response to statin treatment and susceptibility to statin-induced adverse drug reactions in Asians: a scoping review.

Yow HY, Hamzah S, Abdul Rahim N, Suppiah V. Yow HY, et al. Asian Biomed (Res Rev News). 2023 Oct 9;17(3):95-114. doi: 10.2478/abm-2023-0050. eCollection 2023 Jun. Asian Biomed (Res Rev News). 2023. PMID: 37818163 Free PMC article. Review.

5

Pharmacogenomics of Cancer Pain Treatment Outcomes in Asian Populations: A Review.

Satkunananthan SE, Suppiah V, Toh GT, Yow HY. Satkunananthan SE, et al. Among authors: yow hy. J Pers Med. 2022 Nov 18;12(11):1927. doi: 10.3390/jpm12111927. J Pers Med. 2022. PMID: 36422103 Free PMC article. Review.

6

The Effects and Mechanisms of Xanthones in Alzheimer's Disease: A Systematic Review.

Pang LW, Hamzah S, Tan SLJ, Mah SH, Yow HY. Pang LW, et al. Among authors: yow hy. Neurochem Res. 2023 Dec;48(12):3485-3511. doi: 10.1007/s11064-023-04005-8. Epub 2023 Aug 14. Neurochem Res. 2023. PMID: 37578655 Review.

7

Optimizing Antimicrobial Therapy by Integrating Multi-Omics With Pharmacokinetic/Pharmacodynamic Models and Precision Dosing.

Yow HY, Govindaraju K, Lim AH, Abdul Rahim N. Yow HY, et al. Front Pharmacol. 2022 Jun 23;13:915355. doi: 10.3389/fphar.2022.915355. eCollection 2022. Front Pharmacol. 2022. PMID: 35814236 Free PMC article. Review.

8

Targeting Mutant-p53 for Cancer Treatment: Are We There Yet?

Lim DV, Woo WH, Lim JX, Loh XY, Soh HT, Lim SYA, Lee ZY, Yow HY, Hamzah SB, Sellappans R, Foo JB. Lim DV, et al. Among authors: yow hy. Curr Mol Pharmacol. 2024;17(1):e140923221042. doi: 10.2174/1874467217666230914090621. Curr Mol Pharmacol. 2024. PMID: 37711005 Review.

9

Understanding methiopropamine, a new psychoactive substance: an in-depth review on its chemistry, pharmacology and implications to human health.

Bunaim MK, Damanhuri HA, Yow HY, Yaakob NS, Makmor-Bakry M, Azmi N. Bunaim MK, et al. Among authors: yow hy. Int J Legal Med. 2024 Mar 1. doi: 10.1007/s00414-024-03201-7. Online ahead of print. Int J Legal Med. 2024. PMID: 38424369 Review.

10

Exploring the rise of telehealth services in Malaysia: A retrospective study.

Loo JS, Yow HY, Ten YY, Govindaraju K, Megat Mohd Zubairi MH, Oui HC, Abdul Rahim N. Loo JS, et al. Among authors: yow hy. Digit Health. 2023 Nov 21;9:20552076231216275. doi: 10.1177/20552076231216275. eCollection 2023 Jan-Dec. Digit Health. 2023. PMID: 38025110 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year